Maxidex eye drops 0.1%, 5ml

• Allergic blepharitis;

• allergic conjunctivitis;

• allergic keratoconjunctivitis;

• acute and chronic iritis;

• iridocyclitis;

• prevention and treatment of inflammatory reactions in the postoperative period;

• thermal and chemical burns (after complete epithelialization of corneal defects).

The drug is instilled in 1-2 drops into the conjunctival sac of the affected eye (or eyes) every 3-6 hours.

Eye drops 0.1%

1 ml

dexamethasone 1 mg

Excipients: benzalkonium chloride, hydroxypropyl methylcellulose, purified water.

• Viral, bacterial and fungal eye infections;

• corneal diseases in combination with epithelial defects;

• hypersensitivity to the components of the drug.

pharmachologic effect

GCS for local use in ophthalmology. It has a pronounced anti-inflammatory, anti-allergic and desensitizing effect. Dexamethasone actively suppresses inflammatory processes, inhibiting the release of inflammatory mediators by eosinophils, migration of mast cells and reducing capillary permeability. The drug has no mineralocorticoid activity.

Pharmacokinetics

Data on the pharmacokinetics of the drug Maxidex are not provided.

Side effect

From the side of the organ of vision: with prolonged local use of GCS, there may be: increased intraocular pressure with possible subsequent development of glaucoma; posterior subcapsular cataract formation; slowing down the wound healing process (in diseases that cause thinning of the cornea or sclera, perforation of the fibrous membrane is possible). After the use of drugs containing GCS, the development of a secondary infection (including fungal) can be observed, as a result of suppression of the patient's body defense reaction. In acute purulent diseases of the eye, GCS can mask or intensify the existing infectious process. The appearance of non-healing ulcers on the cornea after prolonged treatment with steroid drugs may indicate the development of fungal invasion.

Application during pregnancy and lactation

During pregnancy, Maxidex should be prescribed only in cases where the expected therapeutic effect outweighs the potential risk to the fetus or child. If it is necessary to prescribe the drug during lactation, breastfeeding should be interrupted.

Application in children

Currently, the safety and efficacy of the drug in children have not been established.

special instructions

When using drugs containing GCS for more than 10 days, intraocular pressure should be measured regularly. The drug is intended for topical use only (not for injection). It is not recommended to wear contact lenses during treatment. Avoid touching the dropper tip to any surfaces to avoid microbial contamination of the contents of the vial. Shake the contents of the bottle before use. Use in pediatrics Currently, the safety and efficacy of the drug in children have not been established.

Overdose

Currently, no cases of overdose of the drug Maxidex have been reported.

Drug interactions

Clinically significant drug interaction of Maxidex with other drugs has not been established.